Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Leveraging long-acting IL-15 agonists for intratumoral delivery and enhanced antimetastatic activity
  2. Hangasky, John A; Fernández, Rocío Del Valle; Stellas,Dimitris; Hails, Guillermo; Karaliota,Sevasti; Ashley, Gary W; Felber,Barbara; Pavlakis,George; Santi, Daniel V
  3. Frontiers in Immunology. 2024, Nov 4; 15: 1458145.
  1. 2.   Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI
  2. Lindenberg, Liza; Mena, Esther; Turkbey, Baris; Shih, Joanna H; Reese, Sarah E; Harmon,Stephanie; Lim, Ilhan; Lin, Frank; Ton, Anita; McKinney, Yolanda L; Eclarinal, Philip; Citrin, Deborah E; Dahut, William; Madan, Ravi; Wood, Bradford J; Krishnasamy, Venkatesh; Chang, Richard; Levy, Elliot; Pinto, Peter; Eary, Janet F; Choyke, Peter L
  3. Radiology. 2020, SEP; 296(3): 564-572.
  1. 3.   State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach
  2. Levy, Elliot B; Fiel, Maria I; Hamilton, Stanley R; Kleiner, David E; McCall, Shannon J; Schirmacher, Peter; Travis, William; Kuo, Michael D; Suh, Robert D; Tam, Alda L; Islam, Shaheen U; Ferry-Galow,Katherine; Enos, Rebecca A; Doroshow, James H; Makhlouf, Hala R
  3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020, MAY 10; 38(14): 1633-+.
  1. 4.   Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma
  2. Zhu, Shanli; Chen, Jun; Xiong, Yirong; Kamara, Saidu; Gu, Meiping; Tang, Wanlin; Chen, Shao; Dong, Haiyan; Xue, Xiangyang; Zheng,Zhi-Ming; Zhang, Lifang
  3. PLoS pathogens. 2020, Jan 06; 16(1): e1008223.
  1. 5.   Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation
  2. Kinsella, Timothy; Safran, Howard; Wiersma, Susan; DiPetrillo, Thomas; Schumacher, Andrew; Rosati, Kayla; Vatkevich, John; Anderson, Lawrence W.; Hill,Kimberly; Kunos, Charles; Collins,Jerry
  3. CLINICAL CANCER RESEARCH. 2019, Oct 15; 25(20): 6035-6043.
  1. 6.   Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively via Red Fluorescent Protein Labeled Stromal Cells
  2. Park, Jun Ho; Zhao, Ming; Oshiro, Hiromichi; Miyake, Kentaro; Higuchi, Takashi; Reynoso, Jose; Razmjooei, Sahar; Bouvet, Michael; Clary, Bryan; Zhang, Zhiying; Sugisawa, Norihiko; Yamamoto, Jun; Singh,Shree Ram; Hoffman, Robert M
  3. Anticancer research. 2019, Jul; 39(7): 3463-3467.
  1. 7.   A comparison of prostate cancer bone metastases on 18F-Sodium Fluoride and Prostate Specific Membrane Antigen (18F-PSMA) PET/CT: Discordant uptake in the same lesion
  2. Harmon,Stephanie; Mena, Esther; Shih, Joanna H; Adler,Stephen; McKinney, Yolanda; Bergvall, Ethan; Mehralivand, Sherif; Sowalsky, Adam G; Couvillon, Anna; Madan, Ravi A; Gulley, James L; Eary, Janet; Mease, Ronnie C; Pomper, Martin G; Dahut, William L; Turkbey, Baris; Lindenberg, Liza; Choyke, Peter L
  3. Oncotarget. 2018, Dec 28; 9(102): 37676-37688.
  1. 8.   Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization
  2. Chen, X. H.; Peer, C. J.; Alfaro, R.; Tian, T.; Spencer, S. D.; Figg, W. D.
  3. Journal of Pharmaceutical and Biomedical Analysis. 2012, Mar; 62: 140-148.
  1. 9.   Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals
  2. Bhattacharyya, S.; Dixit, M.
  3. Dalton Transactions. 2011, Jun 21; 40(23): 6112-6128.
  1. 10.   Bioluminescent imaging study FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models
  2. Sun, H. H.; Pisle, S.; Gardner, E. R.; Figg, W. D.
  3. Cancer Biology & Therapy. 2010, Jul; 10(1): 38-43.
  1. 11.   Breast cancer bone metastases Combination therapy targeting cancer cells and the tumor microenvironment
  2. de Kluyver, R. L.; Sayers, T. J.
  3. Cancer Biology & Therapy. 2010, Apr; 9(7): 551-553.
  1. 12.   Two-Step Synthesis of Galactosylated Human Serum Albumin as a Targeted Optical Imaging Agent for Peritoneal Carcinomatosis
  2. Regino, C. A. S.; Ogawa, M.; Alford, R.; Wong, K. J.; Kosaka, N.; Williams, M.; Feild, B. J.; Takahashi, M.; Choyke, P. L.; Kobayashi, H.
  3. Journal of Medicinal Chemistry. 2010, Feb; 53(4): 1579-1586.
  1. 13.   Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain
  2. Palmieri, D.; Bronder, J. L.; Herring, J. M.; Yoneda, T.; Weil, R. J.; Stark, A. M.; Kurek, R.; Vega-Valle, E.; Feigenbaum, L.; Halverson, D.; Vortmeyer, A. O.; Steinberg, S. M.; Aldape, K.; Steeg, P. S.
  3. Cancer Research. 2007, May; 67(9): 4190-4198.
  1. 14.   The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiograpgy in central nervous system malignancy: A pilot study
  2. Neuwelt, E. A.; Varallyay, C. G.; Manninger, S.; Solymosi, D.; Haluska, M.; Hunt, M. A.; Nesbit, G.; Stevens, A.; Jerosch-Herold, M.; Jacobs, P. M.; Hoffman, J. M.
  3. Neurosurgery. 2007, Apr; 60(4): 601-611.
  1. 15.   Detection of lymph node involvement in hematologic malignancies using micromagnetic resonance lymphangiography with a gadolinum-labeled dendrimer nanoparticle
  2. Kobayashi, H.; Kawamoto, S.; Brechbiel, M. W.; Bernardo, M.; Sato, N.; Waldmann, T. A.; Tagaya, Y.; Choyke, P. L.
  3. Neoplasia. 2005, Nov; 7(11): 984-991.
  1. 16.   In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative
  2. Hollingshead, M.; Alley, M.; Burger, A. M.; Borgel, S.; Pacula-Cox, C.; Fiebig, H. H.; Sausville, E. A.
  3. Cancer Chemotherapy and Pharmacology. 2005, AUG; 56(2): 115-125.
  1. 17.   In vivo hydrodynamic delivery of cDNA encoding IL-2: Rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells
  2. Ortaldo, J. R.; Winkler-Pickett, R. T.; Bere, E. W.; Watanabe, M.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2005, JUL 15; 175(2): 693-699.
  1. 18.   Topotecan blocks hypoxia-inducible factor-1 alpha, and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells
  2. Beppu, Y.; Nakamura, K.; Linehan, W. M.; Rapisarda, A.; Thiele, C. J.
  3. Cancer Research. 2005, JUN 1; 65(11): 4775-4781.
  1. 19.   Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer
  2. Palmieri, D.; Halverson, D. O.; Ouatas, T.; Horak, C. E.; Salerno, M.; Johnson, J.; Figg, W. D.; Hollingshead, M.; Hursting, S.; Berrigan, D.; Steinberg, S. M.; Merino, M. J.; Steeg, P. S.
  3. Journal of the National Cancer Institute. 2005, MAY 4; 97(9): 632-642.
  1. 20.   Immunologic and therapeutic synergy of IL-27 and IL-2: Complete regression of neuroblastoma metastases in the liver and bone marrow
  2. Salcedo, R.; Hixon, J.; Stauffer, J.; Kha, T.; Lincoln, E.; Back, T.; Kastelein, R.; Wigginton, J.
  3. Journal of Immunotherapy. 2005, NOV-DEC; 28(6): 625-625.
  1. 21.   IL-18 plus IL-12 decreases liver metastases through An NK cell, IFN-gamma dependent mechanism and overcomes NK/T cell mediated suppression
  2. Subleski, A.; Back, T. C.; Ortaldo, J. R.; Wiltrout, R. H.
  3. Journal of Immunotherapy. 2005, NOV-DEC; 28(6): 626-626.
  1. 22.   NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer
  2. Smyth, M. J.; Swann, J.; Kelly, J. M.; Cretney, E.; Yokoyama, W. M.; Diefenbach, A.; Sayers, T. J.; Hayakawa, Y.
  3. Journal of Experimental Medicine. 2004, NOV 15; 200(10): 1325-1335.
  1. 23.   Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy
  2. Takeda, K.; Yamaguchi, N.; Akiba, H.; Kojima, Y.; Hayakawa, Y.; Tanner, J. E.; Sayers, T. J.; Seki, N.; Okumura, K.; Yagita, H.; Smyth, M. J.
  3. Journal of Experimental Medicine. 2004 199(4): 437-448.
  1. 24.   Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2)
  2. Park, J. W.; Gruys, M. E.; McCormick, K.; Lee, J. K.; Subleski, J.; Wigginton, J. M.; Fenton, R. G.; Wang, J. M.; Wiltrout, R. H.
  3. Journal of Immunology. 2001 166(6): 3763-3770.
  1. 25.   Regulation and antimetastatic functions of liver-associated natural killer cells
  2. Wiltrout, R. H.
  3. Immunological Reviews. 2000 174: 63-76.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel